Propofol pharmacokinetics in young healthy Indian subjects

被引:9
|
作者
Puri, Avinash [1 ]
Medhi, Bikash [2 ]
Panda, Nidhi B. [1 ]
Puri, G. D. [1 ]
Dhawan, Sanju [3 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Anesthesia, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India
[3] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
Anesthetics; propofol; pharmacokinetics; volume of distribution; TARGET-CONTROLLED INFUSION; DISPOSITION;
D O I
10.4103/0253-7613.96348
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To analyze population pharmacokinetics of Propofol in Indian patients after single bolus dose of Propofol using WINNONLIN program. Materials and Methods: Population pharmacokinetics of Propofol was investigated in Indian subjects in 26 elective surgical patients (14 males and 12 females) following single bolus dose of 2 mg/kg propofol. A total of 364 samples were estimated by High Performance Liquid Chromatography and pharmacokinetic parameters were derived using WINNONLIN (5.2). The effect of demographic characters of the study population on pharmacokinetic parameters was investigated. Results: Three-compartment model was used to describe the pharmacokinetic data of Propofol in Indian subjects. Initial volume of distribution (V1) clearance (Cl) and steady state volume of distribution (Vd(ss)) was 13.5 +/- 3.3 l, 1.08 +/- 0.42 l/min, and 77.69 +/- 48.0 l, respectively. Body weight best described the volume of central compartment (V1) as well as elimination clearance (P<0.01). Conclusion: Pharmacokinetics of Propofol in young healthy Indian subjects show lower volume of distribution and clearance as compared with most of the western data. Body weight best describes the V1, Vd(ss), and Clearance in this group.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 50 条
  • [21] Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects
    Akamizu, T
    Takaya, K
    Irako, T
    Hosoda, H
    Teramukai, S
    Matsuyama, A
    Tada, H
    Miura, K
    Shimizu, A
    Fukushima, M
    Yokode, M
    Tanaka, K
    Kangawa, K
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (04) : 447 - 455
  • [22] SINGLE DOSE PHARMACOKINETICS OF KETOROLAC IN HEALTHY-YOUNG AND RENAL IMPAIRED SUBJECTS
    MARTINEZ, JJ
    GARG, DC
    PAGES, LJ
    JALLAD, NS
    YEE, JP
    MROSZCACK, ES
    RENNEKE, GA
    WEIDLER, DJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (09): : 722 - 722
  • [23] Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment
    Barbhaiya, RH
    Shukla, UA
    Greene, DS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 49 (03) : 221 - 228
  • [24] Effect of dexmedetomidine on propofol requirements in healthy subjects
    Dutta, S
    Karol, MD
    Cohen, T
    Jones, RM
    Mant, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (02) : 172 - 181
  • [25] Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects
    Marino, MR
    Langenbacher, K
    Ford, NF
    Uderman, HD
    JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (03): : 246 - 255
  • [26] PHARMACOKINETICS OF RILMENIDINE IN HEALTHY-SUBJECTS
    GENISSEL, P
    BROMET, N
    FOURTILLAN, JB
    MIGNOT, A
    ALBIN, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (07): : D47 - D53
  • [27] PHARMACOKINETICS OF AZLOCILLIN IN HEALTHY-SUBJECTS
    LEROY, A
    HUMBERT, G
    FILLASTRE, JP
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1981, : 49 - 54
  • [28] Population Pharmacokinetics of Dasatinib in Healthy Subjects
    Hassouneh, Walaa B.
    Al-Ghazawi, Mutasim A.
    Saleh, Mohammad I.
    Najib, Naji
    PHARMACEUTICALS, 2024, 17 (06)
  • [29] Pharmacokinetics of rizatriptan in healthy elderly subjects
    Musson, DG
    Birk, KL
    Panebianco, DL
    Gagliano, KD
    Rogers, JD
    Goldberg, MR
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (10) : 447 - 452
  • [30] Population pharmacokinetics of onercept in healthy subjects
    Glatt, S
    Fuseau, E
    Buraglio, M
    Nguyen, QTX
    CLINICAL PHARMACOKINETICS, 2005, 44 (12) : 1295 - 1304